Fueling Next-Generation MS Disease Progression Research with Valhalla Foundation Support – Read the Release

Contact Us

Comparison of Multiple Sclerosis Disease Activity (MSDA) Test Results Between Patients Treated with Ublituximab and Teriflunomide in the Phase 3 ULTIMATE I and II Studies

September 27, 2024inByCommentNo Comments
Click here